CerMed International has received CE mark approval for its CerMap cervical specimen collection device.

CerMap provides a technique for collecting cervical cells, used in cervical cancer screening procedures.

The approval allows the company to sell the product throughout the European Economic Area.

The company intends to file for US Food and Drug Administration 510(k) clearance for CerMap in the near future.